Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group
- PMID: 6146820
- DOI: 10.1016/s0140-6736(84)90311-8
Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group
Abstract
A mass screening system for the early detection by means of a vanillylmandelic acid test of neuroblastoma in 6-month-old infants in Japan has been developed in eight districts. 16 of the 281 939 infants screened by this test had neuroblastoma, equivalent to a very high incidence of 1 in 17 621. 15 of the 16 children with neuroblastoma are alive; the other child died 1 month after surgery. This mass screening system for neuroblastoma used in infancy can help to improve prognosis in infants with this malignant disorder.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
